Surfing the MASH Tsunami

Surfing the MASH Tsunami

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(1073)

S5 - E4.6 - From The Vault: What a NASH Disease Model Reveals About Treating Advanced Fibrosis

S5 - E4.6 - From The Vault: What a NASH Disease Model Reveals About Treating Advanced Fibrosis

Send us Fan Mail Two years ago, Surfing the MASH Tsunami conducted two episodes with Chris Estes, then the chief modeler for the Center for Disease Analysis Foundation exploring issues around CDAF's t...

3 Mar 202415min

S5 - E4.5 - MASH Education As A Tool To Stem The MASLD Pandemic

S5 - E4.5 - MASH Education As A Tool To Stem The MASLD Pandemic

Send us Fan Mail As the episode comes to an end, the group winds up focusing on the need for better, more frequent MASH education as a pivotal need if we are to flatten the growth curve of the MASLD p...

3 Mar 20249min

S5 - E 4.4 - Learning about the Global NASH Council's work in MASLD

S5 - E 4.4 - Learning about the Global NASH Council's work in MASLD

Send us Fan Mail This conversation focuses largely on the work of the Global NASH Council, an effort of over 200 stakeholders in more than 50 countries to address a range of macro issues in the MASLD ...

3 Mar 20248min

S5 - E4.1 - Appreciating The Disease Burden Of MASLD

S5 - E4.1 - Appreciating The Disease Burden Of MASLD

Send us Fan Mail In this opening conversation on MASLD disease burden, Zobair Younossi summarizes and expands on some key points from the recent Diabetes Spectrum review article he co-authored with Li...

3 Mar 202411min

S5 - E4.2 - The Breadth Of MASLD Disease Burden And Cost Effectiveness Of Therapies

S5 - E4.2 - The Breadth Of MASLD Disease Burden And Cost Effectiveness Of Therapies

Send us Fan Mail Initially, this conversation focuses on how cost-effectiveness issues relate to the MASLD Disease Burden. In the process, Zobair Younossi provides education on some of the metrics and...

3 Mar 202410min

S5 - E4.3 - Slowing The Growth Of The MASLD Pandemic

S5 - E4.3 - Slowing The Growth Of The MASLD Pandemic

Send us Fan Mail This conversation starts with a focus on slowing the growth of the MASLD pandemic, and then veers slightly into a discussion of the specific issues post-menopausal women face with MAS...

3 Mar 202410min

S5 - E4 - MASLD Epidemiology Takes: Rapidly Proliferating Prevalence; Many Public Health Needs

S5 - E4 - MASLD Epidemiology Takes: Rapidly Proliferating Prevalence; Many Public Health Needs

Send us Fan Mail Zobair Younossi, Chair of the Global NASL Council, publishes seminal papers on MASLD epidemology, cost of disease, and related public health needs regularly. Co-hosts Jörn Schattenbe...

29 Feb 202452min

S5 - E3.6 - From the Vault: EASL Congress 2023: Focus On The New MASLD Nomenclature

S5 - E3.6 - From the Vault: EASL Congress 2023: Focus On The New MASLD Nomenclature

Send us Fan Mail Our first conversation focusing on the new MASLD nomenclature surfaces as part of our coverage of the EASL Congress 2023. Hepatology researchers and key opinion leaders Sven Francque ...

27 Feb 202415min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
forskningno
liberal-halvtime
sinnsyn
rekommandert
vett-og-vitenskap-med-gaute-einevoll
villmarksliv
dekodet-2
rss-nysgjerrige-norge
diagnose
tomprat-med-gunnar-tjomlid
rss-rekommandert
rss-inn-til-kjernen-med-sunniva-rose
rss-skogkurs-podden
fjellsportpodden
rss-overskuddsliv
hva-er-greia-med
nevropodden